Detalhe da pesquisa
1.
Phase II study of pegylated liposomal doxorubicin, low-dose dexamethasone, and lenalidomide in patients with newly diagnosed multiple myeloma.
Am J Hematol
; 89(1): 62-7, 2014 Jan.
Artigo
em Inglês
| MEDLINE | ID: mdl-24030918
2.
Mature results of MM-011: a phase I/II trial of liposomal doxorubicin, vincristine, dexamethasone, and lenalidomide combination therapy followed by lenalidomide maintenance for relapsed/refractory multiple myeloma.
Am J Hematol
; 89(4): 349-54, 2014 Apr.
Artigo
em Inglês
| MEDLINE | ID: mdl-24273135
3.
Incidence of therapy-related myeloid neoplasia after initial therapy for chronic lymphocytic leukemia with fludarabine-cyclophosphamide versus fludarabine: long-term follow-up of US Intergroup Study E2997.
Blood
; 118(13): 3525-7, 2011 Sep 29.
Artigo
em Inglês
| MEDLINE | ID: mdl-21803850
4.
Lenalidomide and high-dose dexamethasone compared with dexamethasone as initial therapy for multiple myeloma: a randomized Southwest Oncology Group trial (S0232).
Blood
; 116(26): 5838-41, 2010 Dec 23.
Artigo
em Inglês
| MEDLINE | ID: mdl-20876454
5.
G1P3, an IFN-induced survival factor, antagonizes TRAIL-induced apoptosis in human myeloma cells.
J Clin Invest
; 117(10): 3107-17, 2007 Oct.
Artigo
em Inglês
| MEDLINE | ID: mdl-17823654
6.
An association between renal cell carcinoma and multiple myeloma: a case series and clinical implications.
BJU Int
; 101(6): 712-5, 2008 Mar.
Artigo
em Inglês
| MEDLINE | ID: mdl-17970789
7.
Disease and outcome disparities in multiple myeloma: exploring the role of race/ethnicity in the Cooperative Group clinical trials.
Blood Cancer J
; 8(7): 67, 2018 07 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-29980678
8.
Preclinical rationale, mechanisms of action, and clinical activity of anthracyclines in myeloma.
Clin Lymphoma Myeloma
; 7 Suppl 4: S145-9, 2007 Apr.
Artigo
em Inglês
| MEDLINE | ID: mdl-17562252
9.
Proteasome inhibitors in the clinical setting: benefits and strategies to overcome multiple myeloma resistance to proteasome inhibitors.
Drugs R D
; 8(1): 1-12, 2007.
Artigo
em Inglês
| MEDLINE | ID: mdl-17249845
10.
The Role of Minimal Residual Disease Testing in Myeloma Treatment Selection and Drug Development: Current Value and Future Applications.
Clin Cancer Res
; 23(15): 3980-3993, 2017 Aug 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-28428191
11.
Thromboembolism risk reduction in multiple myeloma patients treated with immunomodulatory drug combinations.
Thromb Haemost
; 95(6): 924-30, 2006 Jun.
Artigo
em Inglês
| MEDLINE | ID: mdl-16732369
12.
Phase 2 study of pegylated liposomal doxorubicin, vincristine, decreased-frequency dexamethasone, and thalidomide in newly diagnosed and relapsed-refractory multiple myeloma.
Mayo Clin Proc
; 81(7): 889-95, 2006 Jul.
Artigo
em Inglês
| MEDLINE | ID: mdl-16835968
13.
Immunomodulatory analogues of thalidomide in the treatment of multiple myeloma.
Clin Lymphoma Myeloma
; 6(4): 301-5, 2006 Jan.
Artigo
em Inglês
| MEDLINE | ID: mdl-16507207
14.
Lenalidomide: patient management strategies.
Semin Hematol
; 42(4 Suppl 4): S22-5, 2005 Oct.
Artigo
em Inglês
| MEDLINE | ID: mdl-16344098
15.
The role of aspirin in the prevention of thrombotic complications of thalidomide and anthracycline-based chemotherapy for multiple myeloma.
Mayo Clin Proc
; 80(12): 1568-74, 2005 Dec.
Artigo
em Inglês
| MEDLINE | ID: mdl-16342649
16.
Advances in multiple myeloma and spine disease.
Clin Lymphoma Myeloma
; 6(3): 228-33, 2005 Nov.
Artigo
em Inglês
| MEDLINE | ID: mdl-16354328
17.
Incidence and risk factors of venous thromboembolism (VTD) in patients with amyloidosis.
Int Semin Surg Oncol
; 2: 17, 2005 Sep 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-16138931
18.
Cytogenetic prioritization with inclusion of molecular markers predicts outcome in previously untreated patients with chronic lymphocytic leukemia treated with fludarabine or fludarabine plus cyclophosphamide: a long-term follow-up study of the US intergroup phase III trial E2997.
Leuk Lymphoma
; 56(11): 3031-7, 2015.
Artigo
em Inglês
| MEDLINE | ID: mdl-25721902
19.
New treatment strategies for multiple myeloma.
Semin Hematol
; 41(4 Suppl 7): 2-8, 2004 Oct.
Artigo
em Inglês
| MEDLINE | ID: mdl-15768473
20.
Role of liposomal anthracyclines in the treatment of multiple myeloma.
Semin Oncol
; 31(6 Suppl 13): 147-60, 2004 Dec.
Artigo
em Inglês
| MEDLINE | ID: mdl-15717741